1. |
Blot S, Antonelli M, Arvaniti K, et al. Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project. Intensive Care Med, 2019, 45(12): 1703-1717.
|
2. |
Chou EH, Mann S, Hsu TC, et al. Incidence, trends, and outcomes of infection sites among hospitalizations of sepsis: a nationwide study. PLoS One, 2020, 15(1): e0227752.
|
3. |
况刚, 陈勇, 魏旭升, 等. 24 h LCR、SOFA 评分及 SAPSⅡ评分在腹腔感染致脓毒症患者预后评估中的作用. 湖南师范大学学报(医学版), 2020, 17(1): 26-29.
|
4. |
Qu Z, Zhu Y, Wang M, et al. Prognosis and risk factors of sepsis patients in Chinese ICUs: a retrospective analysis of a cohort database. Shock, 2021, 56(6): 921-926.
|
5. |
Dadkhah A, Fatemi F, Rasooli A, et al. Assessing the effect of Mentha longifolia essential oils on COX-2 expression in animal model of sepsis induced by caecal ligation and puncture. Pharm Biol, 2018, 56(1): 495-504.
|
6. |
刘胜蕊, 史晓峰, 王兵, 等. 腹腔感染性脓毒症可溶性髓样细胞触发受体(sTREM-1)与 Janus 激酶-信号转导和转录激活因子(JAK/STAT)通路的关系. 中华急诊医学杂志, 2016, 25(3): 314-319.
|
7. |
李瑞萍, 宋伟. 血浆 sTREM-1、sFLT-1 及 APACHEⅡ评分对重症肺炎患者预后评估价值. 国际呼吸杂志, 2018, 38(13): 968-971.
|
8. |
Verma AK, Pandey AK, Singh A, et al. Increased serum levels of matrix-metalloproteinase-9, cyclo-oxygenase-2 and prostaglandin E-2 in patients with chronic obstructive pulmonary disease (COPD). Indian J Clin Biochem, 2022, 37(2): 169-177.
|
9. |
中华医学会外科学分会外科感染与重症医学学组, 中国医师协会外科医师分会肠瘘外科医师专业委员会. 中国腹腔感染诊治指南(2019 版). 中国实用外科杂志, 2020, 40(1): 1-16.
|
10. |
中国医师协会急诊医师分会, 中国研究型医院学会休克与脓毒症专业委员会. 中国脓毒症/脓毒性休克急诊治疗指南(2018). 中国急救医学, 2018, 38(9): 741-756.
|
11. |
魏锋, 洪志敏, 董海涛, 等. ICU 重度脓毒症的流行病学特点及预后影响因素的分析. 中华医院感染学杂志, 2018, 28(10): 1469-1471, 1484.
|
12. |
陶丽丽, 张振辉, 张瑞昌, 等. 综合 ICU 内腹腔感染相关性脓毒症患者的临床特征分析. 国际医药卫生导报, 2018, 24(23): 3604-3606.
|
13. |
Wang L, Chen Q, Yu Q, et al. ITREM-1 aggravates chronic obstructive pulmonary disease development via activation NLRP3 inflammasome-mediated pyroptosis. Inflamm Res, 2021, 70(9): 971-980.
|
14. |
Wang X, Luo B, Lu Y, et al. The triggering receptor expressed by myeloid cells-1 activates TLR4-MyD88-NF-κB-dependent signaling to aggravate ventilation-induced lung inflammation and injury in mice. Cell Tissue Res, 2018, 374(1): 137-148.
|
15. |
Gonçalves RM, Delgobo M, Agnes JP, et al. COX-2 promotes mammary adipose tissue inflammation, local estrogen biosynthesis, and carcinogenesis in high-sugar/fat diet treated mice. Cancer Lett, 2021, 1(502): 44-57.
|
16. |
Xie Y, Li X, Lv D, et al. TREM-1 amplifies trophoblastic inflammation via activating NF-κB pathway during preeclampsia. Placenta, 2021, 115: 97-105.
|
17. |
Tang J, Dong Q, Tang J, et al. Knockdown of TREM-1 suppresses IL-1β-induced chondrocyte injury via inhibiting the NF-κB pathway. Biochem Biophys Res Commun, 2017, 482(4): 1240-1245.
|
18. |
Joung EJ, Cao L, Lee B, et al. Sargahydroquinoic acid, a cyclooxygenase-2 inhibitor, attenuates inflammatory responses by regulating NF-κB inactivation and Nrf2 activation in lipopolysaccharide-stimulated cells. Inflammation, 2021, 44(5): 2120-2131.
|